Rchr
J-GLOBAL ID：200901053019845251
Update date: Jan. 17, 2024
Ashizawa Tadashi
アシザワ タダシ | Ashizawa Tadashi
Contact this researcher
You can send email directly to the researcher.
Affiliation and department：
Shizuoka Cancer Center, Research Institute Immunotherapy Division
About Shizuoka Cancer Center, Research Institute Immunotherapy Division
Search "Shizuoka Cancer Center, Research Institute Immunotherapy Division"
Detailed information
Job title：
Senior Scientist
Research field (2)：
Pharmacology
, Pharmaceuticals - health and biochemistry
Research keywords (5)：
腫瘍免疫
, 分子標的治療
, Cell
, Transcription Devices/control
, Animal Experimental Technology
Research theme for competitive and other funds (2)：
2006 - 2010 新規抗がん剤(分子標的薬)のin vivoスクリーニング
2006 - 2010 In vivo screening molecularly targeted anti-cancer drugs
Papers (4)：
Tadashi Ashizawa, Akira Iizuka, Chizu Nonomura, Ryota Kondou, Chie Maeda, Haruo Miyata, Takashi Sugino, Koichi Mitsuya, Nakamasa Hayashi, Yoko Nakasu, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. CLINICAL CANCER RESEARCH. 2017. 23. 1. 149-158
Tadashi Ashizawa, Yasuto Akiyama, Haruo Miyata, Akira Iizuka, Masaru Komiyama, Akiko Kume, Maho Omiya, Takashi Sugino, Akira Asai, Nakamasa Hayashi, et al. Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line. INTERNATIONAL JOURNAL OF ONCOLOGY. 2014. 45. 1. 411-418
Tadashi Ashizawa, Haruo Miyata, Akira Iizuka, Masaru Komiyama, Chie Oshita, Akiko Kume, Masahiro Nogami, Mika Yagoto, Ichiro Ito, Takuma Oishi, et al. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma. INTERNATIONAL JOURNAL OF ONCOLOGY. 2013. 43. 1. 219-227
Tadashi Ashizawa, Haruo Miyata, Hidee Ishii, Chie Oshita, Kenji Matsuno, Yoshiaki Masuda, Toshio Furuya, Tadashi Okawara, Masami Otsuka, Naohisa Ogo, et al. Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation. INTERNATIONAL JOURNAL OF ONCOLOGY. 2011. 38. 5. 1245-1252
Association Membership(s) (1)：
THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
